Over the past few weeks in Victoria and other parts of Australia, we've been seeing some wild and stormy weather.

Fewer patients with hypereosinophilic syndrome receiving benralizumab plus background therapy vs. placebo had flares, ...

Dirt isn’t the enemy but over-sanitization can be A little mess a little outdoor play and a life that includes both hygiene and natural exposure can keep allergies at bay and keep your immune system s ...

Approval based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIn the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

A doctor advising ... sleepaway camp? That's how a 12-year-old diagnosed with lupus found himself laughing on a high-ropes ...

Dupixent has gained EU approval as the first targeted therapy in more than ten years for chronic spontaneous urticaria, ...

THERE are few things as satisfying as scratching an itch. But when your itch keeps recurring and starts to affect your day-to ...

Allergy Treatment Market OverviewThe global allergy treatment market is poised for consistent growth, projected to expand at ...

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria ...

Proportion of patients with complete response (UAS7=0).

After months of training, the Walker Fire Department says it has added new life-saving medical skills to its toolbox.

In this video, Gailen D. Marshall Jr., MD, PhD, chair of allergy and immunology at University of Mississippi Medical Center, ...